Vimarsana
Biggest News Aggregation in the World

Page 3 - Technology Access Framework News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Access Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Access Framework Today - Breaking & Trending Today

Harvard University licenses its nasal swab collection technology to Rhinostics - Vimarsana News

Harvard University licenses its nasal swab collection technology to Rhinostics

 E-Mail IMAGE: A research team at the Wyss Institute and Harvard Medical School has developed a nasal swab collection technology enabling high-throughput automated sample processing for molecular diagnosis of respiratory diseases including... view more  Credit: Wyss Institute at Harvard University (Boston) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and Harvard Medical School (HMS) and the Massachusetts-based startup Rhinostics announced today that the University's sample collection swab and high-throughput automation technologies have been lic...

INTELLECTUAL PROPERTY PLEDGES FOR COVID-19: A SCORECARD - Vimarsana News

INTELLECTUAL PROPERTY PLEDGES FOR COVID-19: A SCORECARD

**    Duration of WHO-declared COVID-19 pandemic (a)  Wellcome Trust Publishers Pledge The first pandemic-related IP pledge addressed copyrights. On January 31, 2020, the Wellcome Trust, a large UK-based medical charity, led a group of approximately thirty scientific and medical publishers in committing to make all peer-reviewed research publications relating to COVID-19 available without charge on an open access basis. The signatories included Elsevier, Cell Press, Karger, the JAMA Network, the New England Journal of Medicine, Oxford University Press, Springer Nature, Taylor & Francis, W...

New diagnostic platform can rapidly measure COVID-19-related biomarkers - Vimarsana News

New diagnostic platform can rapidly measure COVID-19-related biomarkers

New diagnostic platform can rapidly measure COVID-19-related biomarkers The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with the company's proprietary transistor sensor technology to enable simultaneous electrochemical sensing of multiple biomarkers related to SARS-CoV-2 infection in point-of-care COVID-19 diagnostic applications. The research collaborati...

Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic - Vimarsana News

Harvard's Wyss Institute collaborates with GBS Inc. on eRapid-based COVID-19 diagnostic

 E-Mail IMAGE: The Wyss Institute collaborates with GBS Inc., a subsidiary of The iQ Group Global, to combine its electrochemical eRapid sensing technology with the GBS's transistor technology in developing a multiplexed... view more  Credit: Wyss Institute at Harvard University (BOSTON) -- The Wyss Institute for Biologically Inspired Engineering at Harvard University and GBS Inc., a subsidiary of The iQ Group Global, announce that they will collaborate to validate and de-risk a specific and sensitive COVID-19 diagnostic that would integrate the Institute's eRapid technology with th...